Brazilian Journal of Anesthesiology
https://bjan-sba.org/article/doi/10.1590/S0034-70942006000100011
Brazilian Journal of Anesthesiology
Review Article

Tromboelastógrafo em cirurgia cardíaca: estado atual

Thromboelastograph in cardiac surgery: state of the art

Plínio Vasconcelos Maia; Graciana Zerbini de Araújo; Marcos Daniel de Faria

http://dx.doi.org/10.1590/S0034-70942006000100011 Braz J Anesthesiol, vol.56, n1, p.78-88, 2006
PDF Português
PDF English
Downloads: 0
Views: 1069

Resumo

JUSTIFICATIVA E OBJETIVOS: O manuseio da hemostasia do paciente submetido à circulação extracorpórea (CEC) permanece como um grande desafio. Novos métodos de monitorização, novas drogas hemostáticas e inibidores da função plaquetária vêm sendo incorporados no pré, intra e pós-operatório. A natureza multifatorial dos distúrbios da hemostasia causados pela circulação extracorpórea exige conhecimento da fisiopatologia desses processos e avaliação acurada da hemostasia para anticoagulação eficaz durante a CEC e manutenção de hemostasia adequada após a cirurgia. Tempo de coagulação ativado (TCA) e coagulograma não bastam para esse manuseio. É necessária avaliação mais ampla através de monitores capazes de medir a função plaquetária e a dinâmica do processo hemostático como um todo. CONTEÚDO: A hemostasia é resultado do equilíbrio entre os componentes dos sistemas de coagulação, anticoagulação e fibrinólise. Esse equilíbrio sofre ruptura durante a CEC, tornando o paciente susceptível a sangramento microvascular. A CEC induz alteração no crescimento da força plaquetária e nas propriedades elásticas do coágulo, de etiologia multifatorial. O uso de hemoderivados é constante e surge a necessidade de protocolos para orientar decisões para terapia transfusional. É importante determinar a função plaquetária, através de monitores que medem as propriedades visco-elásticas do coágulo, como tromboelastógrafo (TEG) e Sonoclot. CONCLUSÕES: O tromboelastógrafo é um importante monitor da hemostasia na abordagem dos pacientes submetidos a CEC. Tem sido incorporado com bons resultados nos protocolos de avaliação dos distúrbios hemostáticos e de terapêutica transfusional.

Palavras-chave

CIRURGIA, Cardíaca, MONITORIZAÇÂO

Abstract

BACKGROUND AND OBJECTIVES: Management of hemostasis of cardiopulmonary bypass (CPB) patients is still a major challenge. New monitoring methods, new hemostatic drugs and new platelet function inhibitors are being added to the pre, intra and postoperative periods. The multifactorial nature of CBP-induced hemostasis disorders requires the understanding of their pathophysiology and the accurate hemostasis evaluation for effective coagulation during CPB, in addition to the maintenance of adequate postoperative hemostasis. Activated clotting time (ACT) and coagulogram are not enough for this management. A broader evaluation is needed with monitors able to measure platelet function and hemostatic process dynamics as a whole. CONTENTS: Hemostasis is the result of the balance of coagulation, anticoagulation and fibrinolysis systems components. This balance is disrupted during CPB making patients susceptible to microvascular bleeding. CPB induces multifactorial changes in platelet force growth and clot elastic properties. Blood products are often used and there is the need for protocols to guide transfusion decisions. It is important to determine platelet function with monitors measuring clot visco-elastic properties, such as thromboleastograph (TEG) and Sonoclot. CONCLUSIONS: Thromboelastograph is an important hemostasis monitor for patients submitted to CPB. It has been incorporated to hemostatic disorders evaluation protocols and transfusion therapy, with good results.

Keywords

MONITORING, SURGERY, Cardiac

References

Miana LA, Atik FA, Moreira LF. Fatores de risco de sangramento no pós-operatório de cirurgia cardíaca em pacientes adultos. Braz J Cardiovasc Surg. 2004;19:280-286.

Shore-Lesserson L. Hematologic aspects of cardiac surgery: 54th Annual Refresher Course Lectures, clinical updates and basic science reviews. Am Soc Anesth. 2003:422-428.

Stammers AH, Bruda NL, Gonano C. Point-of-care coagulation monitoring: applications of the thromboelastograph. Anesthesia. 1998;53(^s2):58-59.

Reis CV, Vieira LM, Dusse LMSA. Evaluation of coagulation, fibrinolysis and protein C in risk patients and patients presenting coronarian diseases. J Bras Patol Med Lab. 2003;39:7-13.

Green JA, Spiess BD. Current status of antifibrinolytics in cardiopulmonary bypass and elective deep hypothermic circulatory arrest. Anesthesiol Clin North America. 2003;21:527-551.

Stover EP, Siegel LC, Parks R. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study: Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Anesthesiology. 1998;88:327-333.

Stoelting RK. Pharmacology and Physiology in Anesthetic Practice: Lippincott Williams & Wilkins Interactive Anesthesia Library on CD-ROM Version 3.0. 2001.

Greilich PE, Carr ME Jr, Carr SL. Reductions in platelet force development by cardiopulmonary bypass are associated with hemorrhage. Anesth Analg. 1995;80:459-465.

Petrovitch CT, Drummond JC. Hemoterapia e Hemostasia. Anestesia Clínica. 2004:201-236.

Rinder CS, Mathew JP, Rinder HM. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology. 1991;75:563-570.

Shore-Lesserson L. Monitoring anticoagulation and hemostasis in cardiac surgery. Anesthesiol Clin North America. 2003;21:511-526.

Williams GD, Bratton SL, Riley EC. Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 1999;13:398-404.

Mochizuki T, Olson PJ, Szlam F. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg. 1998;87:781-785.

Miller BE, Williams GD. Bleeding and Coagulation: Monitoring and Management. Anesthesia for Congenital Heart Disease. 2005:157-172.

Shore-Lesserson L. Evidence based coagulation monitors: heparin monitoring, thromboelastography, and platelet function. Semin Cardiothorac Vasc Anesth. 2005;9:41-52.

Stammers AH, Bruda NL, Gonano C. Point-of-care coagulation monitoring: applications of the thromboelastograph. Anaesthesia. 1998;53(^s2):58-59.

Mallett SV. Thromboelastography. Br J Anaesth. 1992;69:307-313.

Whitten CW, Greilich PE. Thromboelastography: past, present, and future. Anesthesiology. 2000;92:1223-1225.

Essell JH, Martin TJ, Salinas J. Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1993;7:410-415.

Cammerer U, Dietrich W, Rampf T. The predictive value of modified computerized thromboelastography an platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg. 2003;96:51-57.

Miller BE, Mochizuki T, Levy JH. Predicting and treating coagulopathies after cardiopulmonary bypass in children. Anesth Analg. 1997;85:1196-1202.

Nuttall GA, Oliver WC, Ereth MH. Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1997;11:815-823.

Shore-Lesserson L, Manspeizer HE, DePerio M. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg. 1999;88:312-319.

Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth. 2001;86:575-578.

Nuttall GA, Oliver WC, Santrach PJ. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology. 2001;94:773-781.

Spiess BD, Gillies BS, Chandler W. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth. 1995;9:168-173.

5dd43b5e0e8825e462c63493 rba Articles
Links & Downloads
2352-2291 (Electronic) 0104-0014 (Printed)
Braz J Anesthesiol ©2024 All rights reserved.

Braz J Anesthesiol

Share this page
Page Sections